Roberto de Ponti

Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland.

OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA.

Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy.

Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland.

Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy.

GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland.

OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA.

Roca Therapeutics SAS is a French company that engages in research and drug development in the fields of oncology, ophthalmology, and immunology. The company is based in Nice, France. The company was founded in 2021. The CEO is Maeva Dufies.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy.

Roca Therapeutics SAS is a French company that engages in research and drug development in the fields of oncology, ophthalmology, and immunology. The company is based in Nice, France. The company was founded in 2021. The CEO is Maeva Dufies.

Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland.

Roca Therapeutics SAS is a French company that engages in research and drug development in the fields of oncology, ophthalmology, and immunology. The company is based in Nice, France. The company was founded in 2021. The CEO is Maeva Dufies.

Roca Therapeutics SAS is a French company that engages in research and drug development in the fields of oncology, ophthalmology, and immunology. The company is based in Nice, France. The company was founded in 2021. The CEO is Maeva Dufies.

Roca Therapeutics SAS is a French company that engages in research and drug development in the fields of oncology, ophthalmology, and immunology. The company is based in Nice, France. The company was founded in 2021. The CEO is Maeva Dufies.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland.

OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA.

Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland.

OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA.

OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

QuantuMDx Group Ltd. develops devices for diagnostics detection. The firm offers DNA-XT, Under The Tree Diagnostics, Q-POC, and Internet of Life. The company was founded by Jonathan O'Halloran, Elaine Warburton, and Julian Warburton in March 2008 and is headquartered in Newcastle upon Tyne, the United Kingdom.

OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA.

Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland.

Stirling Square Capital Partners LLP (Stirling Square Capital Partners) is a private equity firm founded in 2002 by Stefano Bonfiglio and Gregario Napoleone. The firm is headquartered in London, United Kingdom.

3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg.